With increased volume and bullish engulfing pattern which finished double bottom formation, OVAS is an excellent pick to buy this week. Last week global fertility company reported ($0.62) EPS for the quarter, topping analysts’ consensus estimates of ($0.78) by $0.16. The business earned $0.19 million during the quarter, compared to analysts’ expectations of $0.21 million. The business’s revenue was up 530.0% compared to the same quarter last year.